Sui-Ming Wong

Title: Sui-Ming Wong: Innovator in Nanocrystalline Formulations

Introduction

Sui-Ming Wong is a notable inventor based in Collegeville, PA (US), recognized for his contributions to the field of nanotechnology and pharmaceuticals. With a total of 9 patents to his name, Wong has made significant advancements in the treatment of diseases, particularly those related to human immunodeficiency virus (HIV).

Latest Patents

Wong's latest patents focus on methods of treating mammals using nanocrystalline formulations of HIV protease inhibitors. The first patent describes formulations of nanoparticulate HIV protease inhibitors that include a cellulosic surface stabilizer. These nanoparticulate formulations exhibit an increased rate of dissolution in vitro and an enhanced rate of absorption in vivo. Additionally, they demonstrate a decreased fed/fasted ratio variability and reduced variability in absorption. The invention also outlines methods for creating these novel formulations, specifically targeting HIV type 1 (HIV-1) and type 2 (HIV-2) protease inhibitors.

Career Highlights

Throughout his career, Sui-Ming Wong has worked with various companies, including Nanosystems LLC and Elan Pharma International Limited. His work has significantly impacted the pharmaceutical industry, particularly in the development of innovative drug delivery systems.

Collaborations

Wong has collaborated with several professionals in his field, including Shuqian Xu and Gary G. Liversidge. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Sui-Ming Wong's innovative work in nanocrystalline formulations has paved the way for improved treatment options for HIV. His contributions to the field highlight the importance of research and development in creating effective pharmaceutical solutions.